EUVIMED · CrossrefJournal
The Lancet Microbe
ISSN 2666-5247 · Elsevier BV
Latest articles
Advances in tuberculosis diagnostics and biomarkers, 2020–26: scientific evidence, recommendations, gaps, and developmental priorities
Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access
A WHO International Standard for neutralising antibodies to Chikungunya virus: development and evaluation
Non-canonical phage–bacterium interactions during topical phage therapy in the PhagoBurn clinical trial: a retrospective, observational, reverse translational study
The silence of the alarms: Cyclospora and the fragility of foodborne surveillance
Visceral leishmaniasis in Brazil
Female genital schistosomiasis in migrant women: diagnostic challenges in non-endemic settings
Naegleria fowleri in a warming world: epidemiology, genotypic distribution, management challenges, and priorities for public health action
Assessment of Ebola virus persistence in vitreous fluid of Ebola virus disease survivors with vitreoretinal disease in Sierra Leone: a cross-sectional study
Antimicrobial prescribing and guideline adherence in febrile inpatients in the Masanga Fever Study (MaFeStu) in Sierra Leone: a substudy within a prospective observational study
Helminth infections: from genomic discovery to public health interventions
Could the next pandemic be fungal and could we respond effectively? From plausible pathways to operational preparedness
Nasal mucosal humoral responses to SARS-CoV-2 vaccination priming schedules in the UK: a substudy of the Com-COV single-blind, randomised, non-inferiority trial
Intracellular Staphylococcus aureus in human infections: evidence from clinical specimens
Shingles vaccination and cardiovascular disease
Global epidemiology and genetic evolution of enterovirus D68 over a decade (2015–24): a systematic review
Chile eliminates dog-mediated rabies
Africa needs to help model the future of tuberculosis vaccines
Re-securitising antimicrobial resistance: how resurgent health security thinking threatens collective action
Biomarkers for tuberculosis detection, progression, and treatment optimisation: an umbrella review of systematic reviews
No end to tuberculosis without women and children
Cholera spikes in Yemen amid escalating conflict
Slow to see, slower to stop—Bundibugyo virus disease in 2026
IDWeek 2026
Performance of a next-generation rapid lipoarabinomannan urine assay for tuberculosis in outpatients with and without HIV in South Africa and Uganda: a two-centre diagnostic accuracy study
Streptococcus anginosus group as a cause of serious streptococcal infection in the UK: a retrospective population-based surveillance study
Antibiotic overuse and mortality in patients hospitalised for COVID-19: a global cohort study
Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury
Active case-finding: focus on undetected patients with tuberculosis, not asymptomatic patients
Clinical and immunological correlates of CXCR4 coreceptor use in people with HIV-1 receiving antiretroviral therapy in the Netherlands: a multicentre cohort study
EUVIMED